These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12512913)

  • 1. Gene-modified dendritic cells for immunotherapy against cancer.
    Lundqvist A; Pisa P
    Med Oncol; 2002; 19(4):197-211. PubMed ID: 12512913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy using gene-modified dendritic cells.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    Curr Gene Ther; 2002 Feb; 2(1):57-78. PubMed ID: 12108974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells: immunobiology and cancer immunotherapy.
    Ardavín C; Amigorena S; Reis e Sousa C
    Immunity; 2004 Jan; 20(1):17-23. PubMed ID: 14738761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell preparation for immunotherapeutic interventions.
    Simon T; Fonteneau JF; Grégoire M
    Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell maturation in active immunotherapy strategies.
    Morse MA; Mosca PJ; Clay TM; Lyerly HK
    Expert Opin Biol Ther; 2002 Jan; 2(1):35-43. PubMed ID: 11772338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells and their role in cancer immunotherapy.
    Jalili A
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.
    Schreibelt G; Tel J; Sliepen KH; Benitez-Ribas D; Figdor CG; Adema GJ; de Vries IJ
    Cancer Immunol Immunother; 2010 Oct; 59(10):1573-82. PubMed ID: 20204387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
    Hájek R; Butch AW
    Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
    Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
    Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell biology and its role in tumor immunotherapy.
    Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
    J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells: sentinels against pathogens.
    Chung NP; Chen Y; Chan VS; Tam PK; Lin CL
    Histol Histopathol; 2004 Jan; 19(1):317-24. PubMed ID: 14702200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells.
    Nishimura N; Nishioka Y; Shinohara T; Sone S
    Hum Gene Ther; 2001 Mar; 12(4):333-46. PubMed ID: 11242526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
    Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
    Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
    Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
    Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
    Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE
    Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.